BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Newamsterdam secures €1B-plus European commercial deal with Menarini
Armed with compelling phase IIb data and with two phase III trials underway, Newamsterdam Pharma BV has sealed a European commercialization deal worth more than €1 billion...

More in BioWorld

BioWorld MedTech

Acutus stock jumps following expanded FDA clearance
Shares in Acutus Medical Inc. (NASDAQ:AFIB) are trading 50% higher after the arrhythmia management company reported the launch of an expanded suite of its Acqcross...

More in BioWorld MedTech

BioWorld Science

Myelin-forming cells change in multiple brain diseases
Investigators at the Weizmann Institute of Science have identified changes in oligodendrocytes that were shared across multiple dementia types. The team reported its results in the June 27, 2022, online issue of Nature Neuroscience.

More in BioWorld Science

BioWorld Asia

Sutro to develop immunostimulatory ADCs for Astellas targets in deal worth $1.3B
Astellas Pharma Inc. and Sutro Biopharma Inc. signed an exclusive global licensing deal under which Sutro will develop immunostimulatory antibody-drug conjugates (iADCs)...

More in BioWorld Asia

BioWorld Insider Podcast

As multidisciplinary care extends survival and improves the quality of life for people with amyotrophic lateral sclerosis (ALS), can a host of new ALS drugs vying to slow its progression make a difference? Join the BioWorld Insider podcast as we discuss what the future of medicine may hold for ALS patients.